http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022035147-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_581265968346f63692c94fc23fc6bae3 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14 |
filingDate | 2021-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c3071ea28d10f530ae11b8572908593 |
publicationDate | 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2022035147-A1 |
titleOfInvention | Pharmaceutical composition for oral administration, containing (meta)arsenite salt for inhibiting hair loss and promoting hair growth in patient with alopecia that includes alopecia caused by chemotherapy or radiotherapy in cancer patients |
abstract | The present invention contains a (meta)arsenite salt as an active ingredient, and thus provides excellent hair loss prevention or hair growth promotion effects on: patients with common alopecia caused by overactivity of androgenic hormones, hypersecretion of sebum, poor blood circulation, scalp dysfunction due to peroxides or bacteria, genetic factors, aging, stress and the like; and alopecia in cancer patients in which hair loss is caused by chemotherapy or radiotherapy for cancer treatment. The described composition according to the present invention enables cancer to be overcome with only a single effect and, when co-administered as an adjuvant in other cancer therapies, can prevent hair loss during cancer treatment while improving cancer treatment effects, and thus can increase overall anti-cancer treatment effects and prevent cancer patients from becoming stressed by hair loss caused by anti-cancer treatment. |
priorityDate | 2020-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.